- Home
- SMTC vs OGN Comparison
SMTC vs OGN Comparison
Compare SMTC & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTC
- OGN
- Stock Information
- Founded
- SMTC 1960
- OGN 1923
- Country
- SMTC United States
- OGN United States
- Employees
- SMTC 1917
- OGN N/A
- Industry
- SMTC Semiconductors
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- SMTC Technology
- OGN Health Care
- Exchange
- SMTC Nasdaq
- OGN Nasdaq
- Market Cap
- SMTC 3.2B
- OGN 4.0B
- IPO Year
- SMTC N/A
- OGN N/A
- Fundamental
- Price
- SMTC $37.10
- OGN $15.48
- Analyst Decision
- SMTC Strong Buy
- OGN Hold
- Analyst Count
- SMTC 12
- OGN 5
- Target Price
- SMTC $67.91
- OGN $20.80
- AVG Volume (30 Days)
- SMTC 3.7M
- OGN 2.9M
- Earning Date
- SMTC 03-27-2025
- OGN 02-13-2025
- Dividend Yield
- SMTC N/A
- OGN 7.23%
- EPS Growth
- SMTC N/A
- OGN N/A
- EPS
- SMTC N/A
- OGN 3.33
- Revenue
- SMTC $851,233,000.00
- OGN $6,403,000,000.00
- Revenue This Year
- SMTC $6.70
- OGN $2.06
- Revenue Next Year
- SMTC $20.71
- OGN $1.85
- P/E Ratio
- SMTC N/A
- OGN $4.65
- Revenue Growth
- SMTC 0.94
- OGN 2.24
- 52 Week Low
- SMTC $19.76
- OGN $13.87
- 52 Week High
- SMTC $79.52
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- SMTC 29.94
- OGN 50.46
- Support Level
- SMTC $36.11
- OGN $15.26
- Resistance Level
- SMTC $39.86
- OGN $15.90
- Average True Range (ATR)
- SMTC 2.99
- OGN 0.63
- MACD
- SMTC -1.62
- OGN 0.04
- Stochastic Oscillator
- SMTC 3.73
- OGN 35.19
About SMTC Semtech Corporation
Semtech Corp is engaged in designing, developing, manufacturing and marketing analog and mixed-signal semiconductors, algorithms and wireless semiconductors, connectivity modules, gateways, routers and connected services for IoT. The company operates in four reportable segments' 1) Signal Integrity, 2) Advanced Protection and Sensing, 3) IoT System and 4) IoT Connected Services. The majority of the company's revenue is earned through Advanced Protection and Sensing Products segment. Geographically majority of the company's revenue is earned from Asia Pacific region.
About OGN Organon & Co.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.